Mangalam Drugs And Organics Ltd.
NSE: MANGALAM | BSE: 532637
₹28.83
₹-0.06
(-0.21%)
As on 27-May-2026IST
Market cap
₹46 Cr
Revenue (TTM)
₹233 Cr
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-44 Cr
-
ROE
4.8 %
-
ROCE
8.6 %
-
Industry P/E
46.86
-
EV/EBITDA
-10.4
-
Debt to Equity
0.1
-
Book Value
₹65.1
-
EPS
₹-28.1
-
Face value
10
-
Shares outstanding
15,828,248
10 Years Aggregate
CFO
₹279.28 Cr
EBITDA
₹349.67 Cr
Net Profit
₹104.97 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mangalam Drugs
| 4.8 | 3.8 | -3.8 | -64.9 | -35.6 | -26.4 | 4.6 |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Mangalam Drugs
| -77.0 | 16.1 | -28.4 | 5.4 | -5.9 | 388.4 | -61.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mangalam Drugs
|
28.8 | 45.7 | 232.7 | -44.4 | -14.0 | -38.5 | -- | 0.4 |
| 3,000.6 | 24,577.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 69 | 14.9 | |
| 428.8 | 16,406.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.5 | 4.2 | |
| 782.6 | 19,421.1 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.6 | 3.8 | |
| 991.8 | 15,788.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.6 | 2.2 | |
| 1,175.8 | 21,056.2 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.5 | 2.4 | |
| 1,791.1 | 20,554.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 174.2 | 23,155.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 460.4 | 18,574.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.7 | 3.8 | |
| 1,771.0 | 28,787.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 135.2 | 5.8 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Research Desk
About Mangalam Drugs
Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir,... amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base; and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising l(+)menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol. Further, it manufactures organic and inorganic chemicals, and heavy chemicals. Additionally, it offers active pharmaceutical ingredients; and products covering various therapeutic areas comprising anti-malaria, anti-retroviral, anti-hypertensive, anti-inflammatory, anti-convulsant, anti-viral, anti-rheumatic arthritis agents, and anti-bacterial, as well as develops product for anti-hypertensive indications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India. Read more
-
Incorporated
1972
-
Chairman
Govardhan M Dhoot
-
Managing Director
Govardhan M Dhoot
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Mangalam Drugs And Organics Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Mangalam Drugs
What is the current share price of Mangalam Drugs And Organics Ltd Today?
The share price of Mangalam Drugs And Organics Ltd is ₹28.83 (NSE) and ₹28.90 (BSE) as of 27-May-2026 IST. Mangalam Drugs And Organics Ltd has given a return of -35.64% in the last 3 years.
What is the current PB & PE ratio of Mangalam Drugs And Organics Ltd?
Since, TTM earnings of Mangalam Drugs And Organics Ltd is negative, P/E ratio is not available.
The P/B ratio of Mangalam Drugs And Organics Ltd is 0.44 times as on 27-May-2026, a 89 discount to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
17.48
|
0.83
|
|
2024
|
0.00
|
1.08
|
|
2023
|
121.95
|
1.02
|
|
2022
|
8.28
|
1.08
|
|
2021
|
5.62
|
1.20
|
What is the 52 Week High and Low of Mangalam Drugs And Organics Ltd?
The 52-week high and low of Mangalam Drugs And Organics Ltd are Rs 95.00 and Rs 22.80 as of 28-May-2026.
What is the market cap of Mangalam Drugs And Organics Ltd?
Mangalam Drugs And Organics Ltd has a market capitalisation of ₹ 46 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Mangalam Drugs And Organics Ltd?
Before investing in Mangalam Drugs And Organics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.